List view / Grid view
4 July 2016 | By Victoria White, Digital Content Producer
Scientists have shown that NEAT1, a non-coding RNA, plays an important role in the survival of highly dividing cells - and in particular of cancer cells...
4 July 2016 | By Victoria White, Digital Content Producer
Using a mouse model that mimics the development of Alzheimer’s, scientists have determined the biological “insults” that must occur to cause dementia...
1 July 2016 | By Victoria White, Digital Content Producer
Researchers have developed an E. coli-based transport capsule designed to help next-generation vaccines do a more effective job than today's immunisations...
1 July 2016 | By Victoria White, Digital Content Producer
Novo Nordisk and Aarhus University's Science and Technology faculty are to collaborate to strengthen protein technology research and development...
30 June 2016 | By Victoria White, Digital Content Producer
Scientists identified a natural molecular pathway that enables cells to burn off calories as heat rather than store them as fat...
30 June 2016 | By Victoria White, Digital Content Producer
An experimental vaccine against Zika virus has been tested successfully in trials with mice, giving 100% protection...
30 June 2016 | By Victoria White, Digital Content Producer
The partnership will allow Probiodrug to utilise Crossbeta’s proprietary technology in support of Probiodrug’s biomarker development activities...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have examined the proteomes of 169 ovarian cancer patients to identify critical proteins expressed by their tumours...
29 June 2016 | By Victoria White, Digital Content Producer
Moderna and MSD will develop personalised cancer vaccines that utilise Moderna’s mRNA vaccine technology to encode a patient’s specific neoantigens...
29 June 2016 | By Victoria White, Digital Content Producer
A study suggests efavirenz might be an effective therapy for stimulating cholesterol turnover from the brain and slowing or preventing Alzheimer's disease...
29 June 2016 | By Victoria White, Digital Content Producer
Scientists have described a strategy to stabilise an important HIV structure and potentially create HIV lookalikes for large-scale vaccine production...
29 June 2016 | By Victoria White, Digital Content Producer
Heptares Therapeutics and leadXpro are to employ powerful new approaches for the determination of high-resolution X-ray structures of GPCRs...
28 June 2016 | By Victoria White, Digital Content Producer
Nordic Nanovector and AREVA Med have entered into a collaboration agreement to investigate the potential of a 212Pb-conjugated anti-CD37 antibodies...
28 June 2016 | By Victoria White, Digital Content Producer
Storm Therapeutics has secured £12 million in series A funding to identify small molecular drugs that target RNA-modifying enzymes...
28 June 2016 | By Victoria White, Digital Content Producer
Researchers have used virtual tissue technology to identify a potential new drug target in the fight against polycystic kidney disease...
